Adipose Tissue Metabolism and CD11b Expression on Monocytes in Obese Hypertensives

At a given degree of adiposity, metabolic and cardiovascular risk varies markedly between individuals. Animal studies suggest that differentially expressed systemic activation of monocytes contributes to the obesity-associated risk variability. We tested the hypothesis that systemic monocyte activation is associated with changes in adipose tissue and skeletal muscle metabolism. In 17 obese hypertensive patients, we assessed CD11b expression on circulating monocytes, gene expression in adipose tissue biopsies, and obtained blood samples and adipose tissue and skeletal muscle microdialysis samples in the fasted state and during a glucose load. Patients were stratified into groups with higher and lower CD11b expression on monocytes. Expression of the macrophage marker CD68 was increased markedly in adipose tissue of subjects with higher CD11b expression. Although no differences in systemic insulin sensitivity were found between both groups, patients with higher peripheral CD11b expression showed a markedly augmented increase in dialysate glucose in adipose tissue during oral glucose tolerance testing and increased adipose tissue lipolysis as well. Our data demonstrate that human monocyte activation is associated with tissue-specific changes in glucose and lipid metabolism. These findings may be explained in part by monocyte/macrophage infiltration of adipose tissue, which appears to interfere with insulin responsiveness.

[1]  Y. Halvorsen,et al.  Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice. , 2005, Endocrinology.

[2]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  A. Aljada,et al.  Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State , 2004, Circulation.

[4]  L. Niskanen,et al.  C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men , 2004, Diabetologia.

[5]  R. Paschke,et al.  Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. , 2004, Biochemical and biophysical research communications.

[6]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[7]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[8]  H. Kotani,et al.  Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice* , 2003, Journal of Biological Chemistry.

[9]  L. Køber,et al.  Tumor Necrosis Factor-&agr; Inhibits Insulin’s Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in Humans , 2003, Circulation.

[10]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Arya M. Sharma,et al.  Association between adiponectin and mediators of inflammation in obese women. , 2003, Diabetes.

[12]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[13]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[14]  R. Wolf.  Task Force on Developing Obesity Outcomes and Learning Standards (TOOLS). Proceedings of a symposium. Warrenton, Virginia, USA. June 11-13, 1999. , 2002, Obesity research.

[15]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[16]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[17]  N. Christensen,et al.  Interaction between β-Adrenergic Receptor Stimulation and Nitric Oxide Release on Tissue Perfusion and Metabolism1 , 2001 .

[18]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[19]  G. Shulman,et al.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.

[20]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[21]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[22]  U. Ungerstedt,et al.  Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. , 1995, Journal of applied physiology.

[23]  S. L. Nielsen,et al.  Relationship of subcutaneous adipose tissue blood flow to thickness of subcutaneous tissue and total body fat mass. , 1973, Scandinavian journal of clinical and laboratory investigation.

[24]  B. Richelsen,et al.  Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects , 2005, International Journal of Obesity.

[25]  P. Murdock,et al.  Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. , 2003, Biochemical and biophysical research communications.

[26]  Arya M. Sharma,et al.  Resistin gene expression in human adipocytes is not related to insulin resistance. , 2002, Obesity research.

[27]  N. Christensen,et al.  Interaction between beta-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. , 2001, The Journal of clinical endocrinology and metabolism.